Literature DB >> 24549331

Signaling via tumor necrosis factor receptor 1 but not Toll-like receptor 2 contributes significantly to hydrosalpinx development following Chlamydia muridarum infection.

Xiaohua Dong1, Yuanjun Liu, Xiaotong Chang, Lei Lei, Guangming Zhong.   

Abstract

Chlamydial infection in the lower genital tract can lead to hydrosalpinx, which is accompanied by activation of both pattern recognition receptor TLR2- and inflammatory cytokine receptor TNFR1-mediated signaling pathways. In the current study, we compared the relative contributions of these two receptors to chlamydial induction of hydrosalpinx in mice. We found that mice with or without deficiencies in TLR2 or TNFR1 displayed similar time courses of live organism shedding from vaginal swabs, suggesting that these receptor-mediated signaling pathways are not required for controlling chlamydial lower genital infection. However, mice deficient in TNFR1 but not TLR2 developed significantly reduced hydrosalpinx. The decreased pathogenicity correlated with a significant reduction in interleukin-17 by in vitro-restimulated splenocytes of TNFR1-deficient mice. Although TLR2-deficient mice developed hydrosalpinx as severe as that of wild-type mice, peritoneal macrophages from mice deficient in TLR2 but not TNFR1 produced significantly reduced cytokines upon chlamydial stimulation, suggesting that reduced macrophage responses to chlamydial infection do not always lead to a reduction in hydrosalpinx. Thus, we have demonstrated that the signaling pathways triggered by the cytokine receptor TNFR1 play a more significant role in chlamydial induction of hydrosalpinx than those mediated by the pattern recognition receptor TLR2, which has laid a foundation for further revealing the chlamydial pathogenic mechanisms.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24549331      PMCID: PMC3993423          DOI: 10.1128/IAI.01668-13

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

1.  Histopathologic changes related to fibrotic oviduct occlusion after genital tract infection of mice with Chlamydia muridarum.

Authors:  Anita A Shah; Justin H Schripsema; Mohammad T Imtiaz; Ira M Sigar; John Kasimos; Peter G Matos; Sandra Inouye; Kyle H Ramsey
Journal:  Sex Transm Dis       Date:  2005-01       Impact factor: 2.830

2.  Vaccination with the Chlamydia trachomatis major outer membrane protein can elicit an immune response as protective as that resulting from inoculation with live bacteria.

Authors:  Sukumar Pal; Ellena M Peterson; Luis M de la Maza
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

3.  Sexually transmitted diseases and tubal pregnancy.

Authors:  K J Sherman; J R Daling; A Stergachis; N S Weiss; H M Foy; S P Wang; J T Grayston
Journal:  Sex Transm Dis       Date:  1990 Jul-Sep       Impact factor: 2.830

4.  Induction of protective immunity against Chlamydia muridarum intravaginal infection with the chlamydial immunodominant antigen macrophage infectivity potentiator.

Authors:  Chunxue Lu; Bo Peng; Zhihong Li; Lei Lei; Zhongyu Li; Lili Chen; Qingzhi He; Guangming Zhong; Yimou Wu
Journal:  Microbes Infect       Date:  2013-02-14       Impact factor: 2.700

5.  Chlamydia trachomatis antigens recognized in women with tubal factor infertility, normal fertility, and acute infection.

Authors:  Nicole M Budrys; Siqi Gong; Allison K Rodgers; Jie Wang; Christopher Louden; Rochelle Shain; Robert S Schenken; Guangming Zhong
Journal:  Obstet Gynecol       Date:  2012-05       Impact factor: 7.661

6.  Immunogenicity evaluation of a lipidic amino acid-based synthetic peptide vaccine for Chlamydia trachomatis.

Authors:  G Zhong; I Toth; R Reid; R C Brunham
Journal:  J Immunol       Date:  1993-10-01       Impact factor: 5.422

7.  Intracellular interleukin-1alpha mediates interleukin-8 production induced by Chlamydia trachomatis infection via a mechanism independent of type I interleukin-1 receptor.

Authors:  Wen Cheng; Pooja Shivshankar; Youmin Zhong; Ding Chen; Zhongyu Li; Guangming Zhong
Journal:  Infect Immun       Date:  2007-12-17       Impact factor: 3.441

8.  Induction of protective immunity against Chlamydia muridarum intravaginal infection with a chlamydial glycogen phosphorylase.

Authors:  Zhihong Li; Chunxue Lu; Bo Peng; Hao Zeng; Zhiguan Zhou; Yimou Wu; Guangming Zhong
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

9.  Current views of toll-like receptor signaling pathways.

Authors:  Masahiro Yamamoto; Kiyoshi Takeda
Journal:  Gastroenterol Res Pract       Date:  2010-12-14       Impact factor: 2.260

10.  The duration of Chlamydia muridarum genital tract infection and associated chronic pathological changes are reduced in IL-17 knockout mice but protection is not increased further by immunization.

Authors:  Dean W Andrew; Melanie Cochrane; Justin H Schripsema; Kyle H Ramsey; Samantha J Dando; Connor P O'Meara; Peter Timms; Kenneth W Beagley
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

View more
  25 in total

1.  Intrauterine infection with plasmid-free Chlamydia muridarum reveals a critical role of the plasmid in chlamydial ascension and establishes a model for evaluating plasmid-independent pathogenicity.

Authors:  Jianlin Chen; Zhangsheng Yang; Xin Sun; Lingli Tang; Yiling Ding; Min Xue; Zhiguang Zhou; Joel Baseman; Guangming Zhong
Journal:  Infect Immun       Date:  2015-04-13       Impact factor: 3.441

2.  Gastrointestinal Coinfection Promotes Chlamydial Pathogenicity in the Genital Tract.

Authors:  Qi Tian; Zengzi Zhou; Luying Wang; Al-Mutassim Hani Abu-Khdeir; Zhi Huo; Xin Sun; Nu Zhang; Robert Schenken; Yufeng Wang; Min Xue; Guangming Zhong
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

3.  Complement factor C5 but not C3 contributes significantly to hydrosalpinx development in mice infected with Chlamydia muridarum.

Authors:  Zhangsheng Yang; Turner Conrad; Zhou Zhou; Jianlin Chen; Pavel Dutow; Andreas Klos; Guangming Zhong
Journal:  Infect Immun       Date:  2014-05-19       Impact factor: 3.441

4.  Chlamydia muridarum induction of glandular duct dilation in mice.

Authors:  Xin Sun; Zhangsheng Yang; Hongbo Zhang; Jin Dai; Jianlin Chen; Lingli Tang; Sheena Rippentrop; Min Xue; Guangming Zhong; Ganqiu Wu
Journal:  Infect Immun       Date:  2015-03-30       Impact factor: 3.441

5.  Transcriptional profiling of human epithelial cells infected with plasmid-bearing and plasmid-deficient Chlamydia trachomatis.

Authors:  Stephen F Porcella; John H Carlson; Daniel E Sturdevant; Gail L Sturdevant; Kishore Kanakabandi; Kimmo Virtaneva; Hannah Wilder; William M Whitmire; Lihua Song; Harlan D Caldwell
Journal:  Infect Immun       Date:  2014-11-17       Impact factor: 3.441

6.  MicroRNAs Modulate Pathogenesis Resulting from Chlamydial Infection in Mice.

Authors:  Laxmi Yeruva; Dakota L Pouncey; Michael R Eledge; Sudeepa Bhattacharya; Chunqiao Luo; Erin W Weatherford; David M Ojcius; Roger G Rank
Journal:  Infect Immun       Date:  2016-12-29       Impact factor: 3.441

Review 7.  Chlamydia Spreading from the Genital Tract to the Gastrointestinal Tract - A Two-Hit Hypothesis.

Authors:  Guangming Zhong
Journal:  Trends Microbiol       Date:  2017-12-27       Impact factor: 17.079

8.  IL-6-mediated signaling pathways limit Chlamydia muridarum infection and exacerbate its pathogenicity in the mouse genital tract.

Authors:  Xin Sun; Qi Tian; Luying Wang; Min Xue; Guangming Zhong
Journal:  Microbes Infect       Date:  2017-08-31       Impact factor: 2.700

9.  Suppression of Chlamydial Pathogenicity by Nonspecific CD8+ T Lymphocytes.

Authors:  Lingxiang Xie; Conghui He; Jianlin Chen; Lingli Tang; Zhiguang Zhou; Guangming Zhong
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

10.  Endocervical miRNA Expression Profiles in Women Positive for Chlamydia trachomatis with Clinical Signs and/or Symptoms Are Distinct from Those in Women Positive for Chlamydia trachomatis without Signs and Symptoms.

Authors:  Teresa A Batteiger; Nicole Spencer; Charity L Washam; Stephanie Byrum; Michael Eledge; Byron E Batteiger; Roger G Rank; Laxmi Yeruva
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.